Anders Mattsson

4.5k total citations · 1 hit paper
45 papers, 3.5k citations indexed

About

Anders Mattsson is a scholar working on Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anders Mattsson has authored 45 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Pediatrics, Perinatology and Child Health and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anders Mattsson's work include Growth Hormone and Insulin-like Growth Factors (30 papers), Childhood Cancer Survivors' Quality of Life (13 papers) and Pituitary Gland Disorders and Treatments (13 papers). Anders Mattsson is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (30 papers), Childhood Cancer Survivors' Quality of Life (13 papers) and Pituitary Gland Disorders and Treatments (13 papers). Anders Mattsson collaborates with scholars based in Sweden, United States and Belgium. Anders Mattsson's co-authors include Maria Kołtowska‐Häggström, John P. Monson, Erik Holmberg, Gudmundur Johannsson, Nils Wilking, Patrick Wilton, Dale L. Preston, Nancy G. Hildreth, John D. Boice and Roy E. Shore and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Anders Mattsson

45 papers receiving 3.4k citations

Hit Papers

ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF ... 1989 2026 2001 2013 1989 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS
    1989 685 citations Tommy� Fornander, Björn Cedermark et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Mattsson Sweden 30 1.7k 843 580 509 487 45 3.5k
Nadia Haddy France 18 1.2k 0.7× 208 0.2× 514 0.9× 230 0.5× 689 1.4× 70 3.0k
Carolé Rubino France 25 812 0.5× 245 0.3× 502 0.9× 281 0.6× 358 0.7× 51 2.2k
Raymon H. Grogan United States 31 1.8k 1.1× 516 0.6× 558 1.0× 378 0.7× 223 0.5× 83 3.3k
М.D. Тronko Ukraine 34 2.2k 1.3× 525 0.6× 807 1.4× 181 0.4× 1.1k 2.3× 251 3.8k
Françoise Borson‐Chazot France 46 3.4k 2.0× 489 0.6× 1.4k 2.3× 227 0.4× 644 1.3× 227 6.0k
Andrew J. Bauer United States 27 3.0k 1.7× 535 0.6× 487 0.8× 179 0.4× 208 0.4× 111 4.4k
Klaus Mohnike Germany 27 1.0k 0.6× 702 0.8× 233 0.4× 137 0.3× 108 0.2× 112 2.0k
Kristien Boelaert United Kingdom 33 3.4k 1.9× 392 0.5× 360 0.6× 394 0.8× 261 0.5× 86 4.1k
Andrew G. Gianoukakis United States 24 2.2k 1.3× 356 0.4× 622 1.1× 185 0.4× 272 0.6× 63 3.3k
Keith Friend United States 25 1.3k 0.7× 522 0.6× 294 0.5× 302 0.6× 59 0.1× 52 2.9k

Countries citing papers authored by Anders Mattsson

Since Specialization
Citations

This map shows the geographic impact of Anders Mattsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Mattsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Mattsson more than expected).

Fields of papers citing papers by Anders Mattsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Mattsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Mattsson. The network helps show where Anders Mattsson may publish in the future.

Co-authorship network of co-authors of Anders Mattsson

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Mattsson. A scholar is included among the top collaborators of Anders Mattsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Mattsson. Anders Mattsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gardner, Chris J., Anders Mattsson, Christina Daousi, et al.. (2015). GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database. European Journal of Endocrinology. 172(4). 371–381. 44 indexed citations
2.
Vila, Greisa, Ann‐Charlotte Åkerblad, Anders Mattsson, et al.. (2015). Pregnancy outcomes in women with growth hormone deficiency. Fertility and Sterility. 104(5). 1210–1217.e1. 27 indexed citations
3.
Ragnarsson, Óskar, Anders Mattsson, John P. Monson, et al.. (2014). The relationship between glucocorticoid replacement and quality of life in 2737 hypopituitary patients. European Journal of Endocrinology. 171(5). 571–579. 36 indexed citations
4.
Abs, Roger, Anders Mattsson, Maria Thunander, et al.. (2012). Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis. European Journal of Endocrinology. 168(3). 297–305. 42 indexed citations
5.
Gaillard, Rolf C., Anders Mattsson, Ann‐Charlotte Åkerblad, et al.. (2012). Overall and cause-specific mortality in GH-deficient adults on GH replacement. European Journal of Endocrinology. 166(6). 1069–1077. 106 indexed citations
6.
Wilton, Patrick, Anders Mattsson, & Feyza Darendelıler. (2010). Growth Hormone Treatment in Children is not Associated with an Increase in the Incidence of Cancer: Experience from KIGS (Pfizer International Growth Database). The Journal of Pediatrics. 157(2). 265–270. 73 indexed citations
7.
Kołtowska‐Häggström, Maria, Anders Mattsson, & Stephen M. Shalet. (2009). Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations. European Journal of Endocrinology. 161(suppl_1). S51–S64. 37 indexed citations
8.
Mattsson, Anders, et al.. (2008). Total and cause-specific mortality in patients from the KIMS database: direct evidence for a beneficial effect of GH replacement therapy on mortality in adult GH deficient patients. 16. 2 indexed citations
9.
Mattsson, Anders, et al.. (2008). Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults. Growth Hormone & IGF Research. 18(6). 506–516. 32 indexed citations
10.
Svensson, Johan, Nick Finer, Pierre Bouloux, et al.. (2007). Growth hormone (GH) replacement therapy in GH deficient adults: Predictors of one-year metabolic and clinical response. Growth Hormone & IGF Research. 17(1). 67–76. 22 indexed citations
11.
Saller, Bernhard, Anders Mattsson, Peter Herbert Kann, et al.. (2006). Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults – comparison between Sweden, The Netherlands and Germany. European Journal of Endocrinology. 154(6). 843–850. 35 indexed citations
12.
Abs, Roger, Ulla Feldt‐Rasmussen, Anders Mattsson, et al.. (2006). Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults – a KIMS database analysis. European Journal of Endocrinology. 155(1). 79–90. 116 indexed citations
13.
Abs, Roger, Anders Mattsson, Bengt‐Åke Bengtsson, et al.. (2005). Isolated growth hormone (GH) deficiency in adult patients: Baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database. Growth Hormone & IGF Research. 15(5). 349–359. 70 indexed citations
14.
15.
Preston, Dale L., Anders Mattsson, Erik Holmberg, et al.. (2002). Radiation Effects on Breast Cancer Risk: A Pooled Analysis of Eight Cohorts. Radiation Research. 158(2). 220–235. 389 indexed citations
16.
Dalberg, Kristina, Anders Mattsson, Kerstin Sandelin, & Lars Erik Rutqvist. (1998). Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer. Breast Cancer Research and Treatment. 49(1). 69–78. 95 indexed citations
17.
Björnhagen, Viveca, et al.. (1993). Morphometric, DNA and PCNA in thin malignant melanomas. Medical Oncology and Tumor Pharmacotherapy. 10(3). 87–94. 8 indexed citations
18.
Mattsson, Anders, et al.. (1993). Radiation-Induced Breast Cancer: Long-Term Follow-up of Radiation Therapy for Benign Breast Disease. JNCI Journal of the National Cancer Institute. 85(20). 1679–1685. 92 indexed citations
19.
Merk, K., Britta Mattsson, Anders Mattsson, et al.. (1990). The Incidence of Cancer among Blood Donors. International Journal of Epidemiology. 19(3). 505–509. 75 indexed citations
20.
Fornander, Tommy�, Björn Cedermark, Anders Mattsson, et al.. (1989). ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS. The Lancet. 333(8630). 117–120. 685 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadia Haddy Breakdown of academic impact, for papers by Carolé Rubino Breakdown of academic impact, for papers by Raymon H. Grogan Breakdown of academic impact, for papers by М.D. Тronko Breakdown of academic impact, for papers by Françoise Borson‐Chazot Breakdown of academic impact, for papers by Andrew J. Bauer Breakdown of academic impact, for papers by Klaus Mohnike Breakdown of academic impact, for papers by Kristien Boelaert Breakdown of academic impact, for papers by Andrew G. Gianoukakis Breakdown of academic impact, for papers by Keith Friend
Rankless by CCL
2026